Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry

Lignende værker

• Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis
  af: Harrold, Leslie R., et al.
  Udgivet: (2017)
• Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
  af: Pappas, Dimitrios A., et al.
  Udgivet: (2021)
• Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
  af: Pappas, Dimitrios A., et al.
  Udgivet: (2020)
• Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry
  af: Harrold, Leslie R., et al.
  Udgivet: (2016)
• Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry
  af: Harrold, Leslie R., et al.
  Udgivet: (2015)